GOSSAMER BIO, INC. Earnings Per Share (Basic)
GOSSAMER BIO, INC. (GOSS) reported Earnings Per Share (Basic) of $0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- GOSSAMER BIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.05.
- GOSSAMER BIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.20.
- GOSSAMER BIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.21.
- GOSSAMER BIO, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.17, a 177.27% decline year-over-year.
- GOSSAMER BIO, INC. earnings per share, basic for fiscal 2025 was -$0.75.
- GOSSAMER BIO, INC. earnings per share, basic for fiscal 2024 was -$0.25.
- GOSSAMER BIO, INC. earnings per share, basic for fiscal 2023 was -$1.18.
- GOSSAMER BIO, INC. earnings per share, basic for fiscal 2022 was -$2.71.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.05 10-Q · filed 2026-08-13 | -$0.11 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | -$0.20 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | -$0.75 10-K · filed 2026-03-17 | |||
| 2025-09-30 | -$0.21 10-Q · filed 2025-11-05 | -$0.54 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | -$0.17 10-Q · filed 2026-08-13 | -$0.33 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | -$0.16 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | -$0.25 10-K · filed 2026-03-17 | |||
| 2024-09-30 | -$0.14 10-Q · filed 2025-11-05 | -$0.10 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $0.22 10-Q · filed 2025-08-05 | $0.03 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | -$0.19 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$1.18 10-K · filed 2026-03-17 | |||
| 2023-09-30 | -$0.21 10-Q · filed 2024-11-07 | -$1.03 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | -$0.45 10-Q · filed 2024-08-12 | -$0.96 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$0.52 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$2.71 10-K · filed 2025-03-13 | |||
| 2022-09-30 | -$0.65 10-Q · filed 2023-11-09 | -$2.14 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.74 10-Q · filed 2023-08-08 | -$1.50 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.76 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | -$3.13 10-K · filed 2024-03-05 | |||
| 2021-09-30 | -$0.80 10-Q · filed 2022-11-03 | -$2.38 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$0.80 10-Q · filed 2022-08-09 | -$1.58 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$0.78 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$3.55 10-K · filed 2023-03-17 | |||
| 2020-09-30 | -$0.80 10-Q · filed 2021-11-08 | -$2.67 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$1.00 10-Q · filed 2021-08-09 | -$1.88 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | -$0.87 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$3.29 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |